Clover Corporation Limited (CLV) Q2 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Thank you for standing by and welcome to the COVID Corporation Limited HY26 results briefing. All participants are in a listen only mode. There will be a presentation followed by a question and answer session. If you wish to ask a question, you will need to press the star key followed by the number one on your telephone keypad. I would now like to hand the conference over to Mr. Peter Davey, Managing Director and CEO. Please go ahead. Good morning all. Welcome to the first half FY26 investor presentation. I'm delighted to be with you and present some good results. I'm Peter Davy and he is Andrew Elegon. Andrew is the Company Secretary and CFO. He will take us through the financial part of the results and following the presentation we're happy to take questions from you. So if I move to the highlights of the first half financial year, revenue was up $6.5 million to $44.1 million. That's a record result for the company, so an outstanding revenue result, which has driven our gross margins up to 35.6% as well. The revenue has really been generated with new customers and some of our other customers really improving their results as well. So a mixture of the two, which is driving an improved revenue result. EBITDA, $6.9 million up $2.6 million on the prior period by half has been outstanding. That's really underpinned by... The new product mix of products that we've got, so that's delivering better margins, delivering with new customers, and an improved manufacturing performance across the entire business. Cash on the balance sheet is sitting at $10.3 million. That's offset a little bit by we've had to increase our inventory position by $10.2 million, and that's really just in response to the improved customer demand. We've tried to flex our inventory position relative to ...